The clinical efficacy of captopril combined with simvastatin for treating patients with early diabetic nephropathy
10.3760/cma.j.issn.1008-6706.2012.18.020
- VernacularTitle:卡托普利联合辛伐他汀治疗早期糖尿病肾病临床观察
- Author:
Guizhen YANG
- Publication Type:Journal Article
- Keywords:
Diabetic nephropathg;
Captopril;
Simvastatin
- From:
Chinese Journal of Primary Medicine and Pharmacy
2012;19(18):2758-2759
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the clinical efficacy of captopril combined with simvastatin for treating patients with early diabetic nephropathy.Methods 180 patients with diabetic nephropathy were randomly divided into three groups,and each group had 60 cases,group A was given captopril for treatment,group B was given simvastatin and group C was received captopril and simvastatin for treatment.The clinical efficacy,renal function before and after treatment and incidence of adverse reactions were compared in three groups.Results The clinical efficacy of group C was significantly better than group A and group B ( P ＜ 0.05 ) ; after treatment,the value of Ma/Cr,SCR and Bun of three groups were lower than pre-treatment ( t =3.12,3.08,3.17,3.41,3.19,3.20,3.04,3.44,3.48,all P ＜ 0.05 ) ;and the value of Ma/Cr,SCR and Bun after treatment in group C were significantly lower than group A and group B ( t =4.58,4.69,5.02,4.89,5.11,4.87,all P ＜0.05 ) ;the incidence of adverse reactions in group C was significantly lower than the other two groups.Conclusion Captopril combined with simvastatin could significantly improve the clinical efficacy of the early diabetic nephropathy and had small side effects.
